Isabella C Glitza Oliva
Isabella C Glitza Oliva
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,✉,#,
Sherise D Ferguson
Sherise D Ferguson
2Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX USA
2,#,
Roland Bassett Jr
Roland Bassett Jr
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX USA
3,
Alexandra P Foster
Alexandra P Foster
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Ida John
Ida John
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Tarin D Hennegan
Tarin D Hennegan
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Michelle Rohlfs
Michelle Rohlfs
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Jessie Richard
Jessie Richard
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Masood Iqbal
Masood Iqbal
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Tina Dett
Tina Dett
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Carol Lacey
Carol Lacey
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Natalie Jackson
Natalie Jackson
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Theresa Rodgers
Theresa Rodgers
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Suzanne Phillips
Suzanne Phillips
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Sheila Duncan
Sheila Duncan
4Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
4,
Lauren Haydu
Lauren Haydu
4Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
4,
Ruitao Lin
Ruitao Lin
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,3,
Rodabe N Amaria
Rodabe N Amaria
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Michael K Wong
Michael K Wong
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Adi Diab
Adi Diab
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Cassian Yee
Cassian Yee
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Sapna P Patel
Sapna P Patel
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Jennifer L McQuade
Jennifer L McQuade
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Grant M Fischer
Grant M Fischer
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Ian E McCutcheon
Ian E McCutcheon
2Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX USA
2,
Barbara J O’Brien
Barbara J O’Brien
5Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
5,
Sudhakar Tummala
Sudhakar Tummala
5Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
5,
Matthew Debnam
Matthew Debnam
6Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
6,
Nandita Guha-Thakurta
Nandita Guha-Thakurta
6Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
6,
Jennifer A Wargo
Jennifer A Wargo
4Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
4,
Fernando C L Carapeto
Fernando C L Carapeto
7Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
7,
Courtney W Hudgens
Courtney W Hudgens
7Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
7,
Jason T Huse
Jason T Huse
8Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
8,
Michael T Tetzlaff
Michael T Tetzlaff
9Department of Pathology, University of California San Francisco, San Francisco, CA USA
9,
Elizabeth M Burton
Elizabeth M Burton
10Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA
10,
Hussein A Tawbi
Hussein A Tawbi
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Michael A Davies
Michael A Davies
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
2Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX USA
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX USA
4Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
5Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
6Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
7Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
8Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA
9Department of Pathology, University of California San Francisco, San Francisco, CA USA
10Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA
Subject terms: Cancer immunotherapy, Phase I trials, CNS cancer, Melanoma
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
